BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 15653019)

  • 1. Health-related quality of life after interventional or conservative strategy in patients with unstable angina or non-ST-segment elevation myocardial infarction: one-year results of the third Randomized Intervention Trial of unstable Angina (RITA-3).
    Kim J; Henderson RA; Pocock SJ; Clayton T; Sculpher MJ; Fox KA;
    J Am Coll Cardiol; 2005 Jan; 45(2):221-8. PubMed ID: 15653019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of different patterns of invasive care on quality of life outcomes in patients with non-ST elevation acute coronary syndrome: results from the GUSTO-IIb Canada-United States substudy.
    Kaul P; Armstrong PW; Fu Y; Knight JD; Clapp-Channing NE; Sutherland W; Granger CB; Mark DB;
    Can J Cardiol; 2004 Jun; 20(8):760-6. PubMed ID: 15229756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health related quality of life after percutaneous coronary intervention versus coronary artery bypass graft surgery in patients with acute coronary syndromes without ST-segment elevation. 12-month follow up.
    Szygula-Jurkiewicz B; Zembala M; Wilczek K; Wojnicz R; Polonski L
    Eur J Cardiothorac Surg; 2005 May; 27(5):882-6. PubMed ID: 15848330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Timing of angiography with a routine invasive strategy and long-term outcomes in non-ST-segment elevation acute coronary syndrome: a collaborative analysis of individual patient data from the FRISC II (Fragmin and Fast Revascularization During Instability in Coronary Artery Disease), ICTUS (Invasive Versus Conservative Treatment in Unstable Coronary Syndromes), and RITA-3 (Intervention Versus Conservative Treatment Strategy in Patients With Unstable Angina or Non-ST Elevation Myocardial Infarction) Trials.
    Damman P; van Geloven N; Wallentin L; Lagerqvist B; Fox KA; Clayton T; Pocock SJ; Hirsch A; Windhausen F; Tijssen JG; de Winter RJ
    JACC Cardiovasc Interv; 2012 Feb; 5(2):191-9. PubMed ID: 22361604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of ranolazine on disease-specific health status and quality of life among patients with acute coronary syndromes: results from the MERLIN-TIMI 36 randomized trial.
    Arnold SV; Morrow DA; Wang K; Lei Y; Mahoney EM; Scirica BM; Braunwald E; Cohen DJ;
    Circ Cardiovasc Qual Outcomes; 2008 Nov; 1(2):107-15. PubMed ID: 20031797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health-related quality of life outcomes of patients with coronary artery disease treated with cardiac surgery, percutaneous coronary intervention or medical management.
    Norris CM; Saunders LD; Ghali WA; Brant R; Galbraith PD; Graham M; Faris P; Dzavik V; Knudtson ML;
    Can J Cardiol; 2004 Oct; 20(12):1259-66. PubMed ID: 15494780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Invasive treatment in unstable coronary artery disease promotes health-related quality of life: results from the FRISC II trial.
    Janzon M; Levin LA; Swahn E
    Am Heart J; 2004 Jul; 148(1):114-21. PubMed ID: 15215800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How should patients with unstable angina and non-ST-segment elevation myocardial infarction be managed? A meta-analysis of randomized trials.
    Choudhry NK; Singh JM; Barolet A; Tomlinson GA; Detsky AS
    Am J Med; 2005 May; 118(5):465-74. PubMed ID: 15866246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of acute coronary syndrome on clinical, economic, and cardiac-specific health status after coronary artery bypass surgery versus stent-assisted percutaneous coronary intervention: 1-year results from the stent or surgery (SoS) trial.
    Zhang Z; Spertus JA; Mahoney EM; Booth J; Nugara F; Stables RH; Weintraub WS
    Am Heart J; 2005 Jul; 150(1):175-81. PubMed ID: 16084166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ST-segment deviation on the admission electrocardiogram, treatment strategy, and outcome in non-ST-elevation acute coronary syndromes A substudy of the Invasive versus Conservative Treatment in Unstable coronary Syndromes (ICTUS) Trial.
    Windhausen F; Hirsch A; Tijssen JG; Cornel JH; Verheugt FW; Klees MI; de Winter RJ;
    J Electrocardiol; 2007; 40(5):408-15. PubMed ID: 17604045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved quality of life after XeCl excimer transmyocardial laser revascularization: results of a randomized trial.
    Huikeshoven M; van der Sloot JA; Tukkie R; van Gemert MJ; Tijssen JG; Beek JF
    Lasers Surg Med; 2003; 33(1):1-7. PubMed ID: 12866115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do men benefit more than women from an interventional strategy in patients with unstable angina or non-ST-elevation myocardial infarction? The impact of gender in the RITA 3 trial.
    Clayton TC; Pocock SJ; Henderson RA; Poole-Wilson PA; Shaw TR; Knight R; Fox KA
    Eur Heart J; 2004 Sep; 25(18):1641-50. PubMed ID: 15351164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of the EQ-5D in patients with a history of acute coronary syndrome.
    Ellis JJ; Eagle KA; Kline-Rogers EM; Erickson SR
    Curr Med Res Opin; 2005 Aug; 21(8):1209-16. PubMed ID: 16083530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gender differences in health-related quality of life following ST-elevation myocardial infarction: women and men do not benefit from primary percutaneous coronary intervention to the same degree.
    Mortensen OS; Bjorner JB; Newman B; Oldenburg B; Groenvold M; Madsen JK; Andersen HR;
    Eur J Cardiovasc Prev Rehabil; 2007 Feb; 14(1):37-43. PubMed ID: 17301625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sex and gender discrepancies in health-related quality of life outcomes among patients with established coronary artery disease.
    Norris CM; Spertus JA; Jensen L; Johnson J; Hegadoren KM; Ghali WA;
    Circ Cardiovasc Qual Outcomes; 2008 Nov; 1(2):123-30. PubMed ID: 20031799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid and sustained improvement in health-related quality of life and utility for 72 weeks in patients with ankylosing spondylitis receiving etanercept.
    Boonen A; Patel V; Traina S; Chiou CF; Maetzel A; Tsuji W
    J Rheumatol; 2008 Apr; 35(4):662-7. PubMed ID: 18278836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cost-effectiveness of an early interventional strategy in non-ST-elevation acute coronary syndrome based on the RITA 3 trial.
    Henriksson M; Epstein DM; Palmer SJ; Sculpher MJ; Clayton TC; Pocock SJ; Henderson RA; Buxton MJ; Fox KA
    Heart; 2008 Jun; 94(6):717-23. PubMed ID: 18032459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The changes of electrocardiogram and impact of early invasive strategy in patients with acute coronary syndromes without ST-segment elevation].
    Zhao MZ; Hu DY; Zhang FC; Wu Y; Yan MY; Wang SW; Mao JM; Yang M; Jiang LQ
    Zhonghua Yi Xue Za Zhi; 2005 Apr; 85(13):879-82. PubMed ID: 16029524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute coronary care in the elderly, part II: ST-segment-elevation myocardial infarction: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology.
    Alexander KP; Newby LK; Armstrong PW; Cannon CP; Gibler WB; Rich MW; Van de Werf F; White HD; Weaver WD; Naylor MD; Gore JM; Krumholz HM; Ohman EM; ;
    Circulation; 2007 May; 115(19):2570-89. PubMed ID: 17502591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical characteristics, in-hospital outcomes and predictors of in-hospital mortality in patients with acute coronary syndromes without persistent ST-segment elevation assigned to early invasive treatment strategy].
    Szyguła-Jurkiewicz B; Wojnicz R; Trzeciak P; Niklewski T; Zembala M; Poloński L
    Przegl Lek; 2005; 62(5):265-9. PubMed ID: 16334529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.